Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
Phase II Trial of Surgical Resection and Heated Intraperitoneal Peritoneal Chemotherapy (HIPEC) for Adrenocortical Carcinoma
Sponsor: Columbia University
A PHASE2 clinical study on Adrenocortical Carcinoma and Peritoneal Carcinomatosis, this trial is actively recruiting participants. The trial is conducted by Columbia University and has accumulated 13 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Nov 2025 — Present [monthly]
Recruiting PHASE2
-
Oct 2024 — Nov 2025 [monthly]
Recruiting PHASE2
-
Sep 2024 — Oct 2024 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Oct 2023 — Jul 2024 [monthly]
Recruiting PHASE2
▶ Show 8 earlier versions
-
Apr 2022 — Oct 2023 [monthly]
Recruiting PHASE2
-
Feb 2021 — Apr 2022 [monthly]
Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE2
-
Sep 2019 — Jan 2021 [monthly]
Recruiting PHASE2
-
Jun 2018 — Sep 2019 [monthly]
Recruiting PHASE2
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE2
-
Sep 2017 — Mar 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
May 2017 — Sep 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Columbia University
For direct contact, visit the study record on ClinicalTrials.gov .